logo

Morphosys Ag (MOR)



Trade MOR now with
  Date
  Headline
10/29/2019 5:14:25 PM MorphoSys Re-affirms FY19 Guidance
10/29/2019 3:58:41 PM MorphoSys Says Primary Endpoint Of Re-MIND Has Been Met
10/28/2019 4:55:17 PM MorphoSys: MOR106 Clinical Development In Atopic Dermatitis Ended For Futility
10/14/2019 7:22:22 AM MorphoSys And I-Mab Biopharma Announce IND Clearance To Begin Clinical Trials Of MOR202/TJ202
9/16/2019 8:18:27 AM MorphoSys's Licensee Janssen Submits Biologics License Application Of Tremfya
8/6/2019 4:19:25 PM MorphoSys Q2 Loss Per Share EUR 0.19 Vs Loss EUR 0.76 Last Year
8/6/2019 4:05:49 PM MorphoSys Report Specifications Of Biomarker Implemented In Phase 3 B-MIND Study
8/6/2019 4:04:20 PM MorphoSys Intends To Submit MAA For Tafasitamab To European Medicines Agency
7/3/2019 7:07:22 AM MorphoSys Boosts FY Guidance Following Milestone Payment From GSK
5/7/2019 4:20:01 PM MorphoSys AG Q1 Group Revenues EUR 13.5 Mln Vs EUR 2.8 Mln Last Year